Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

No benefit of plasma therapy arresting mortality in moderate to severe COVID-19 cases: ICMR

No benefit of plasma therapy arresting mortality in moderate to severe COVID-19 cases: ICMR

Photo Credit :

New Delhi [India], October 6 (ANI): There is no benefit of plasma therapy is arresting mortality in moderate to severe cases of Covid-19, Director General of Indian Council of Medical Research, Balram Bhargava said on Tuesday.
Addressing a press conference here Bhargava said, "An ICMR study has clearly established no benefit of plasma therapy in arresting mortality in moderate to severe cases of Covid-19. Following a cue from it, we have developed horse serum, for which we have got clearance for clinical trial."
Meanwhile, responding to a question, Rajesh Bhushan, Secretary, Union Health secretary said 95 healthcare workers who lost their lives due to Covid-19, insurance of Rs 50 lakh each has been claimed.
"In 95 cases of deaths of healthcare workers engaged in Covid-19 duties, insurance has been claimed for Rs 50 lakhs each. 176 claims are in process. In addition, 79 claims are yet to be received from different states," Bhushan said.
Active Covid-19 cases have been below 10 lakh for the last two weeks in India while the recovery rate is at 84 per cent, the union health ministry said today. (ANI)

Disclaimer: The views expressed in the article above are those of the authors' and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.


Tags assigned to this article:
icmr COVID-19 india Balram Bhargava Rajesh Bhushan insurance

ANI

ANI

More From The Author >>